We are selling Super Retail (SUL) in both the Active Growth & Income Portfolios ahead of their results tomorrow, preferring not to carry the risk.
We are switching from Super Retail (SUL) to JB Hi Fi (JBH) to reduce risk across both the Growth & Income Portfolios. We believe the risk/reward is more appealing in JBH.
We are selling CSL for a loss from the Active Growth Portfolio. This has been a disappointing investment, the only small solace being we have held a significantly lower weight relative to the index.
We are using funds from CSL to buy Resmed (RMD) in the Active Growth Portfolio. We view RMD as a safer opportunity in the healthcare space.